Brief: Lidds Adds Another Scandinavian Clinic To The NZ-DTX-001 Clinical Trial

Lidds AB

05/02/2019 08:53

Feb 5 (Reuters) - Lidds AB  LIDDS.ST :
    * REG-LIDDS ADDS ANOTHER SCANDINAVIAN CLINIC TO THE
NZ-DTX-001
CLINICAL TRIAL
    * RECEIVED APPROVAL FROM DANISH MEDICINES AGENCY (DKMA) TO
CONDUCT
ITS PHASE I NZ-DTX-001 CLINICAL TRIAL
    * EXPECTS TO ENROLL FIRST PATIENTS IN NZ-DTX-001 TRIAL IN Q1
2019.
    * SAYS AIMS TO DEMONSTRATE THAT INTRATUMORAL INJECTIONS WITH
CYTOSTATICS ARE SAFE
    * GOAL IS TO DELIVER DRUGS DIRECTLY INTO CANCER TUMOR

Source text for Eikon:  ID:nGNE6qw3j0 
Further company coverage:  LIDDS.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))